NCT00299624

Brief Summary

Aging is an independent risk factor, without any clear explanation. The primary aim of the study is to depict the effect of aging on the coagulation fibrinolysis parameters and microparticles.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2005

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2005

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 7, 2006

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2006

Completed
Last Updated

September 14, 2010

Status Verified

September 1, 2010

Enrollment Period

10 months

First QC Date

March 6, 2006

Last Update Submit

September 13, 2010

Conditions

Aging

Keywords

venous thromboembolism risk,elderly,hypercoagulabilityfibrinolysismicroparticles

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Stable patients without overt acute clinical event, not receiving antiplatelet or anticoagulant treatment

You may qualify if:

  • age \<40 2 groups : 1 : no history of VTE 2 : history of VTE

You may not qualify if:

  • antiaggregant or anticoagulant therapy at curative dose
  • arterial or thrombotic event in the last month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hopital Lariboisiere

Paris, 75010, France

Location

Hopital Lariboisière

Paris, 75010, France

Location

MeSH Terms

Conditions

Thrombophilia

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • isabelle mahé, MD PhD

    MCU-PH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 6, 2006

First Posted

March 7, 2006

Study Start

October 1, 2005

Primary Completion

August 1, 2006

Study Completion

August 1, 2006

Last Updated

September 14, 2010

Record last verified: 2010-09

Locations

FR(2)